Ongoing studies on the effects of glatiramer acetate (GA, Copaxon, formerly Copoly-mer-1) on IL-5 and IL-13 production in patients with multiple sclerosis have shown that those with a positive clinical response to treatment had elevated serum IL-5 and IL-13 levels [23,24]. The gene discussed is IL13; the disease is multiple sclerosis.